{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:46:08Z","timestamp":1793411168652,"version":"4.5.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.eururo.2016.02.028","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T19:33:40Z","timestamp":1458243220000},"page":"106-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1521,"title":["The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs\u2014Part B: Prostate and Bladder Tumours"],"prefix":"10.1016","volume":"70","author":[{"given":"Peter A.","family":"Humphrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Moch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio L.","family":"Cubilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Ulbright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2016.02.028_bib0685","series-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs","author":"Moch","year":"2016"},{"key":"10.1016\/j.eururo.2016.02.028_bib0690","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/1097-0142(19851001)56:7<1566::AID-CNCR2820560717>3.0.CO;2-Y","article-title":"Ductal spread in prostatic carcinoma","volume":"56","author":"Kovi","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2016.02.028_bib0695","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.5858\/arpa.2015-0206-RA","article-title":"Intraductal carcinoma of the prostate: morphologic features, differential diagnoses, significance, and reporting practices","volume":"139","author":"Magers","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.eururo.2016.02.028_bib0700","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.juro.2015.08.068","article-title":"Intraductal carcinoma of the prostate","volume":"194","author":"Humphrey","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0705","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/00000478-199607000-00003","article-title":"Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations","volume":"20","author":"McNeal","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0710","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/iju.12657","article-title":"Intraductal carcinoma of the prostate: a comprehensive and updated review","volume":"22","author":"Tsuzuki","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0715","doi-asserted-by":"crossref","first-page":"418","DOI":"10.5858\/arpa.2011-0519-RA","article-title":"Intraductal carcinoma of the prostate","volume":"136","author":"Robinson","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.eururo.2016.02.028_bib0720","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.juro.2010.06.017","article-title":"Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings","volume":"184","author":"Robinson","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0725","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/his.12198","article-title":"Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort study","volume":"63","author":"Watts","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.eururo.2016.02.028_bib0730","first-page":"2518","article-title":"Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between \u201cprecursor-like\u201d and \u201cregular type\u201d lesions","volume":"7","author":"Miyai","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0735","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/modpathol.3800702","article-title":"Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance","volume":"19","author":"Guo","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0740","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/PAS.0000000000000348","article-title":"Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy","volume":"39","author":"Morais","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0745","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A contemporary prostate cancer grading system: a validated alternative to the Gleason score","volume":"69","author":"Epstein","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0750","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2559.2011.04039.x","article-title":"Histological variants of prostatic carcinoma and their significance","volume":"60","author":"Humphrey","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.eururo.2016.02.028_bib0755","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PAS.0b013e3181d2a549","article-title":"Microcystic adenocarcinoma of the prostate: a variant of pseudohyperplastic and atrophic patterns","volume":"34","author":"Yaskiv","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0760","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/01.pas.0000209841.77595.4b","article-title":"Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases","volume":"30","author":"Parwani","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0765","doi-asserted-by":"crossref","first-page":"683","DOI":"10.5858\/2005-129-0683-PGCCOT","article-title":"Pleomorphic giant cell carcinoma of the prostate","volume":"129","author":"Lopez-Beltran","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.eururo.2016.02.028_bib0770","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/00000478-200606000-00003","article-title":"Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer","volume":"30","author":"Evans","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0775","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/PAS.0000000000000238","article-title":"Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Epstein","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0780","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/pros.10210","article-title":"Expression of NKX3.1 in normal and malignant tissues","volume":"55","author":"Gelmann","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2016.02.028_bib0785","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/PAS.0b013e3181e6cbf3","article-title":"NKX3.1 as a marker of prostatic origin in metastatic tumors","volume":"34","author":"Gurel","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0790","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/PAS.0b013e3180536678","article-title":"The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate","volume":"31","author":"Sheridan","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0795","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0800","series-title":"Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","first-page":"162","article-title":"Acinar adenocarcinoma","author":"Epstein","year":"2004"},{"key":"10.1016\/j.eururo.2016.02.028_bib0805","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.prp.2014.06.002","article-title":"The association of the cribriform pattern with outcome for prostatic adenocarcinomas","volume":"210","author":"Kir","year":"2014","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.eururo.2016.02.028_bib0810","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1097\/PAS.0b013e3182a02169","article-title":"Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma","volume":"37","author":"Dong","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0815","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/modpathol.2014.116","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0820","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5489\/cuaj.2806","article-title":"Active surveillance for the management of localized prostate cancer: guideline recommendations","volume":"9","author":"Morash","year":"2015","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.eururo.2016.02.028_bib0825","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/jama.281.15.1395","article-title":"Biological determinants of cancer progression in men with prostate cancer","volume":"281","author":"Stamey","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2016.02.028_bib0830","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/cncr.23004","article-title":"Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy","volume":"110","author":"Cheng","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2016.02.028_bib0835","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.eururo.2015.10.029","article-title":"Clinical utility of quantitative Gleason grading in prostate biopsies and prostatectomy specimens","volume":"69","author":"Sauter","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0840","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1464-410X.2012.11611.x","article-title":"Prognostic Gleason grade grouping: data based on the modified Gleason scoring system","volume":"111","author":"Pierorazio","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.02.028_bib0845","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.eururo.2015.10.040","article-title":"Genomic correlates to the newly proposed grading prognostic groups for prostate cancer","volume":"69","author":"Rubin","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0850","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.eururo.2013.05.029","article-title":"The mutational landscape of prostate cancer","volume":"64","author":"Barbieri","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0855","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOU.0000000000000129","article-title":"Genomic rearrangements in prostate cancer","volume":"25","author":"Barbieri","year":"2015","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0860","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.eururo.2016.02.028_bib0865","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.eururo.2016.02.028_bib0870","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0875","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000080828","article-title":"Comparison of WHO 1973, WHO\/ISUP 1998, WHO 1999 grade and combined scoring systems in evaluation of bladder carcinoma","volume":"73","author":"Bircan","year":"2004","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2016.02.028_bib0880","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00428-002-0633-x","article-title":"The WHO\/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems","volume":"441","author":"Busch","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1016\/j.eururo.2016.02.028_bib0885","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/003655901750425837","article-title":"Tumor grade heterogeneity in urothelial bladder carcinoma--proposal of a system using combined numbers","volume":"35","author":"Billis","year":"2001","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0890","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1040-8428(03)00073-8","article-title":"The new World Health Organization\/International Society of Urological Pathology (WHO\/ISUP) classification for TA, T1 bladder tumors: is it an improvement?","volume":"47","author":"Epstein","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0895","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0022-5347(06)00267-9","article-title":"Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts","volume":"175","author":"Jones","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0900","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jcp.56.2.91","article-title":"Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies","volume":"56","author":"Montironi","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0905","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0302-2838(02)00028-3","article-title":"Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network","volume":"41","author":"Montironi","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0910","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jjco\/hyt120","article-title":"Clinicopathological analysis of patients with non-muscle-invasive bladder cancer: prognostic value and clinical reliability of the 2004 WHO classification system","volume":"43","author":"Nishiyama","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0915","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1309\/0KATYHQBJD5XHQ8J","article-title":"Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO\/ISUP system by immunophenotyping and follow-up","volume":"121","author":"Yin","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0920","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2012.09.063","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: pathology","volume":"63","author":"Amin","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0925","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/modpathol.2014.158","article-title":"Update for the practicing pathologist: the International Consultation on Urologic Disease-European Association of Urology consultation on bladder cancer","volume":"28","author":"Amin","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0930","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/PAS.0000000000000240","article-title":"Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0935","series-title":"Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","author":"Eble","year":"2004"},{"key":"10.1016\/j.eururo.2016.02.028_bib0940","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1200\/JCO.2003.05.073","article-title":"Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome","volume":"21","author":"van Rhijn","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0945","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/1097-0215(20001120)89:6<514::AID-IJC8>3.0.CO;2-H","article-title":"Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer","volume":"89","author":"Chow","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2016.02.028_bib0950","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0002-9440(10)65318-7","article-title":"Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma","volume":"154","author":"Hartmann","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0955","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/path.1259","article-title":"Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses","volume":"199","author":"Obermann","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0960","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/00313021003767322","article-title":"Papillary urothelial hyperplasia: relationship to urothelial neoplasms","volume":"42","author":"Readal","year":"2010","journal-title":"Pathology."},{"key":"10.1016\/j.eururo.2016.02.028_bib0965","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/00000478-199612000-00007","article-title":"Papillary urothelial hyperplasia. A precursor to papillary neoplasms","volume":"20","author":"Taylor","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0970","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/ijc.21958","article-title":"Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder","volume":"119","author":"van Oers","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2016.02.028_bib0975","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0022-5347(05)66440-3","article-title":"Cystectomy for bladder cancer: a contemporary series","volume":"165","author":"Dalbagni","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0980","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.juro.2012.11.006","article-title":"Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis","volume":"189","author":"Linder","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0985","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.juro.2012.04.020","article-title":"The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma","volume":"188","author":"Kim","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib0990","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ejca.2013.02.001","article-title":"Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy","volume":"49","author":"Xylinas","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2016.02.028_bib0995","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.humpath.2009.03.005","article-title":"Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases","volume":"40","author":"Guo","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1000","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0046-8177(00)80247-6","article-title":"Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 14 patients","volume":"31","author":"Ikegami","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1005","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/PAS.0b013e31805c9cd9","article-title":"Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases","volume":"31","author":"Lagwinski","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1755-8794-6-42","article-title":"Gene profiling suggests a common evolution of bladder cancer subtypes","volume":"6","author":"Hansel","year":"2013","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.eururo.2016.02.028_bib1015","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/modpathol.2012.112","article-title":"Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection","volume":"25","author":"Blochin","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAS.0000000000000524","article-title":"Carcinoma of the uterine cervix unvolving the genitourinary tract: a potential diagnostic dilemma","volume":"40","author":"Schwartz","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1025","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrurol.2014.129","article-title":"Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer","volume":"11","author":"Choi","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1030","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1073\/pnas.1318376111","article-title":"Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology","volume":"111","author":"Damrauer","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.eururo.2016.02.028_bib1035","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/1097-0142(19910415)67:8<2165::AID-CNCR2820670827>3.0.CO;2-M","article-title":"Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases","volume":"67","author":"Grignon","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2016.02.028_bib1040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1464-410X.1998.00718.x","article-title":"Primary adenocarcinoma of the urinary bladder: a report of 185 cases","volume":"82","author":"el-Mekresh","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.urolonc.2005.05.027","article-title":"Long-term results of primary adenocarcinoma of the urinary bladder: A report on 192 patients","volume":"24","author":"Zaghloul","year":"2006","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ajcp\/95.1.13","article-title":"Primary signet-ring cell carcinoma of the urinary bladder","volume":"95","author":"Grignon","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1055","first-page":"414","article-title":"Immunohistochemical demonstration of human chorionic gonadotropin in tumors of the urinary bladder","volume":"15","author":"Yamase","year":"1985","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.eururo.2016.02.028_bib1060","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/PAS.0b013e318222a653","article-title":"Large nested variant of urothelial carcinoma: 23 cases mimicking von brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma","volume":"35","author":"Cox","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/003655901750170425","article-title":"The nested variant of transitional cell carcinoma--a rare neoplasm with poor prognosis","volume":"35","author":"Holmang","year":"2001","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1070","first-page":"989","article-title":"The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology","volume":"9","author":"Drew","year":"1996","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1075","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/01.MP.0000094091.04541.FC","article-title":"Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases","volume":"16","author":"Lin","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1080","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/0046-8177(91)90003-8","article-title":"Unusual forms of carcinoma of the urinary bladder","volume":"22","author":"Young","year":"1991","journal-title":"Hum Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1085","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/ajcp\/96.5.635","article-title":"Microcystic transitional cell carcinomas of the urinary bladder. A report of four cases","volume":"96","author":"Young","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1090","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/00000478-199412000-00005","article-title":"Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma","volume":"18","author":"Amin","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1095","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3109\/00313025.2010.522173","article-title":"Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases","volume":"42","author":"Comperat","year":"2010","journal-title":"Pathology"},{"key":"10.1016\/j.eururo.2016.02.028_bib1100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5858\/133.1.62","article-title":"Micropapillary variant of urothelial carcinoma in the upper urinary tract: a clinicopathologic study of 11 cases","volume":"133","author":"Guo","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.eururo.2016.02.028_bib1105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cncr.22756","article-title":"Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients","volume":"110","author":"Kamat","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2016.02.028_bib1110","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/PAS.0b013e3181ec86b3","article-title":"Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists","volume":"34","author":"Sangoi","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2559.2004.01895.x","article-title":"Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study","volume":"45","author":"Samaratunga","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.eururo.2016.02.028_bib1120","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.juro.2014.02.2565","article-title":"Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder","volume":"192","author":"Spaliviero","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1125","article-title":"Her2 expression in urothelial carcinoma with micropapillary morphology: preferential overexpresssion by the micropapillary component","volume":"93","author":"Huang","year":"2013","journal-title":"Lab Invest"},{"key":"10.1016\/j.eururo.2016.02.028_bib1130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/1078-0432.CCR-13-1992","article-title":"A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma","volume":"20","author":"Ross","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2016.02.028_bib1135","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/modpathol.2013.201","article-title":"Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome","volume":"27","author":"Schneider","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1140","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.urology.2013.12.035","article-title":"Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes","volume":"83","author":"Kaimakliotis","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2016.02.028_bib1145","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.juro.2011.10.145","article-title":"Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread","volume":"187","author":"Ricardo-Gonzalez","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1150","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/PAS.0b013e318159af9e","article-title":"Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases","volume":"32","author":"Ro","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1155","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.juro.2012.11.084","article-title":"Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis","volume":"189","author":"Dayyani","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1160","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.humpath.2012.07.009","article-title":"Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder","volume":"44","author":"Gonzalez-Roibon","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1165","article-title":"E-cadherin (CDH1) is frequently mutated in urothelial carcinoma with signet-ring cell and plasmacytoid morphology","volume":"26","author":"Al-Ahmadie","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/PAS.0b013e318186c45e","article-title":"Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases","volume":"33","author":"Nigwekar","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1175","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00000478-200202000-00005","article-title":"Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems","volume":"26","author":"Oliva","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0046-8177(96)90064-7","article-title":"The histogenesis of clear cell adenocarcinoma of the lower urinary tract. Case series and review of the literature","volume":"27","author":"Drew","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1185","first-page":"615","article-title":"Primary vesical clear cell adenocarcinoma arising in endometriosis: a rare case of mullerian origin","volume":"33","author":"Lah","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.eururo.2016.02.028_bib1190","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/00000478-198511000-00005","article-title":"Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and review of the literature","volume":"9","author":"Young","year":"1985","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1195","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1365-2559.2000.0855e.x","article-title":"Multicentric clear cell adenocarcinoma in the urinary bladder and the urethral diverticulum: evidence of origin of clear cell adenocarcinoma of the female lower urinary tract from Mullerian duct remnants","volume":"36","author":"Mai","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.eururo.2016.02.028_bib1200","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.humpath.2012.11.005","article-title":"The spectrum of histopathologic findings in vesical diverticulum: implications for pathogenesis and staging","volume":"44","author":"Idrees","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.urology.2013.02.015","article-title":"Histopathologic and clinical features of vesical diverticula","volume":"82","author":"Kong","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2016.02.028_bib1210","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrurol.2014.131","article-title":"Diagnosis and management of intradiverticular bladder tumours","volume":"11","author":"Walker","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1215","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.eururo.2006.11.025","article-title":"On the origin of syn- and metachronous urothelial carcinomas","volume":"51","author":"Hoglund","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1220","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.celrep.2014.04.038","article-title":"Mutational context and diverse clonal development in early and late bladder cancer","volume":"7","author":"Nordentoft","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.eururo.2016.02.028_bib1225","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1093\/hmg\/9.20.2973","article-title":"Molecular evolution of multiple recurrent cancers of the bladder","volume":"9","author":"van Tilborg","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.eururo.2016.02.028_bib1230","first-page":"6063","article-title":"Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumors is derived from the same progenitor cells as the teratoma","volume":"63","author":"Brandli","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2016.02.028_bib1235","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/carcin\/bgi310","article-title":"Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?","volume":"27","author":"Knowles","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.eururo.2016.02.028_bib1240","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2013.08.052","article-title":"Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome","volume":"65","author":"Allory","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1245","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cell.2013.01.010","article-title":"The role of telomeres in stem cells and cancer","volume":"152","author":"Gunes","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.eururo.2016.02.028_bib1250","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.critrevonc.2007.04.014","article-title":"A comprehensive systematic review of testicular germ cell tumor surveillance","volume":"64","author":"Groll","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1255","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/ng.2799","article-title":"Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy","volume":"45","author":"Balbas-Martinez","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2016.02.028_bib1260","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2016.02.028_bib1265","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/ng.2798","article-title":"Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation","volume":"45","author":"Guo","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2016.02.028_bib1270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2016.02.028_bib1275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jmg.2010.083790","article-title":"DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome","volume":"48","author":"Slade","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.eururo.2016.02.028_bib1280","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.humpath.2012.11.026","article-title":"Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer","volume":"44","author":"Fahmy","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1285","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.urology.2012.09.007","volume":"81","author":"Chaux","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2016.02.028_bib1290","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/cncr.22588","article-title":"PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression","volume":"109","author":"Inman","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2016.02.028_bib1295","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature13904","article-title":"MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer","volume":"515","author":"Powles","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2016.02.028_bib1300","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/jm401568s","article-title":"[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains","volume":"57","author":"Fedorov","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.eururo.2016.02.028_bib1305","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2016.02.028_bib1310","doi-asserted-by":"crossref","first-page":"9308","DOI":"10.1021\/ja412434f","article-title":"Discovery and optimization of small-molecule ligands for the CBP\/p300 bromodomains","volume":"136","author":"Hay","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.eururo.2016.02.028_bib1315","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.juro.2011.09.008","article-title":"The FGFR3 mutation is related to favorable pT1 bladder cancer","volume":"187","author":"van Rhijn","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1320","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ng.907","article-title":"Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder","volume":"43","author":"Gui","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2016.02.028_bib1325","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1200\/JCO.2012.46.5740","article-title":"Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer","volume":"31","author":"Iyer","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1330","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.eururo.2014.06.050","article-title":"Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder","volume":"67","author":"Kim","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1335","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eururo.2009.09.013","article-title":"Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles","volume":"57","author":"Birkhahn","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1340","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1158\/0008-5472.CAN-09-4213","article-title":"Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome","volume":"70","author":"Lindgren","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2016.02.028_bib1345","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrurol.2011.193","article-title":"Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?","volume":"9","author":"Netto","year":"2012","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1350","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2005.03.2375","article-title":"Defining Molecular Profiles of Poor Outcome in Patients With Invasive Bladder Cancer Using Oligonucleotide Microarrays","volume":"24","author":"Sanchez-Carbayo","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1355","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.juro.2006.09.038","article-title":"Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma","volume":"177","author":"Shariat","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.02.028_bib1360","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MOU.0b013e32832eb45f","article-title":"Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling","volume":"19","author":"van der Kwast","year":"2009","journal-title":"Curr Opin Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283816002050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283816002050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T22:36:13Z","timestamp":1718404573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283816002050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":136,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0302283816002050"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2016.02.028","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs\u2014Part B: Prostate and Bladder Tumours","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2016.02.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}